Bicara Therapeutics Inc (BCAX)
EBITDA Growth
-102.55%
Quarterly · Period ending:
BCAX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-102.55%period ending
Latest reported-102.55%period ending
BCAX Quarterly EBITDA YoY % (-49.66% → -102.55%)
Year-over-year change
High-resolution chart · PNG
BCAX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -102.5515% | |
| -52.6731% | |
| -79.6589% | |
| -107.6377% | |
| -60.3487% | |
| -194.1812% | |
| 19.438% | |
| 23.5389% | |
| -104.0606% | |
| -49.6556% |